Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 836,000 | 786,000 | 897,000 | 1,150,000 | 1,272,194 |
| Accounts receivable | -1,076,000 | -172,000 | 681,000 | 223,000 | -497,739 |
| Accounts payable and accrued liabilities | 1,503,000 | -193,000 | -426,000 | -731,000 | 1,497,147 |
| Other Working Capital | 504,000 | -788,000 | 658,000 | -621,000 | 706,162 |
| Other Operating Activity | 5,768,000 | 3,916,000 | 4,457,000 | 6,324,000 | 3,269,196 |
| Operating Cash Flow | $7,535,000 | $3,549,000 | $6,267,000 | $6,345,000 | $6,246,960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -532,000 | -612,000 | -491,000 | -333,000 | -355,515 |
| Net Acquisitions | -12,452,000 | -622,000 | -405,000 | -688,000 | -272,500 |
| Purchase Of Investment | -851,000 | -1,169,000 | -930,000 | -2,550,000 | -1,943,258 |
| Sale Of Investment | 880,000 | 1,477,000 | 2,705,000 | 1,153,000 | 1,254,931 |
| Other Investing Activity | 19,000 | 0 | 0 | 0 | 1,870,241 |
| Investing Cash Flow | $-12,936,000 | $-926,000 | $879,000 | $-2,418,000 | $553,899 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -19,000 | 12,000 | -601,000 | 1,000,000 | N/A |
| Debt Issued | 20,660,000 | 0 | 0 | 14,586,000 | N/A |
| Debt Repayment | -4,018,000 | N/A | N/A | N/A | -21,086 |
| Common Stock Repurchased | -7,567,000 | -652,000 | -320,000 | N/A | N/A |
| Dividend Paid | -3,294,000 | -2,661,000 | -2,555,000 | N/A | N/A |
| Other Financing Activity | -10,000 | 8,000 | 34,000 | -13,655,000 | -6,761,935 |
| Financing Cash Flow | $5,752,000 | $-3,293,000 | $-3,442,000 | $1,931,000 | $-6,783,021 |
| Exchange Rate Effect | -300,000 | -577,000 | -10,000 | 16,000 | N/A |
| Beginning Cash Position | 8,348,000 | 9,595,000 | 5,901,000 | 27,000 | 9,644 |
| End Cash Position | 8,399,000 | 8,348,000 | 9,595,000 | 5,901,000 | 27,482 |
| Net Cash Flow | $351,000 | $-670,000 | $3,704,000 | $5,858,000 | $17,838 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,535,000 | 3,549,000 | 6,267,000 | 6,345,000 | 6,246,960 |
| Capital Expenditure | -532,000 | -612,000 | -491,000 | -333,000 | -355,515 |
| Free Cash Flow | 7,003,000 | 2,937,000 | 5,776,000 | 6,012,000 | 5,891,445 |